Evidence map›Paper›PMID 42519824›Full record

ArticleSTAR protocols2026

Protocol to study inflammasome activation in induced pluripotent stem cell-derived macrophages.

Chloe M McKee, Melanie Cranston, Emma C McKay, Mohammad Arefian, Ben C Collins, Rebecca C Coll

Abstract read
In one paragraph

Article in STAR protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chloe M McKeeThe Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast, Belfast, UK. Electronic address: chloe.mckee@qub.ac.uk.
Melanie CranstonThe Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast, Belfast, UK.
Emma C McKayThe Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast, Belfast, UK; School of Biological Sciences, Queen's University of Belfast, Belfast, UK.
Mohammad ArefianSchool of Biological Sciences, Queen's University of Belfast, Belfast, UK.
Ben C CollinsSchool of Biological Sciences, Queen's University of Belfast, Belfast, UK.
Rebecca C CollThe Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast, Belfast, UK. Electronic address: r.coll@qub.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophages are widely used to study inflammasome activity, but current in vitro macrophage models have various limitations. Here, we describe a protocol to differentiate induced pluripotent stem cell (iPSC)-derived macrophages (iMacs) and to characterize these cells via flow cytometry, phagocytosis assays, and whole-cell proteomics. We then describe how to activate a range of different inflammasomes within these cells and assess the inflammasome response through measurement of pyroptosis, cytokine release, ASC speck formation, and protein processing via western blotting. For complete details on the use and execution of this protocol, please refer to McKee et al.

Indexed as

Cell cultureCell DifferentiationFlow CytometryImmunologyMass SpectrometryStem Cells

Identifiers

PMID42519824
PMCPMC13449785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.